Newsletters

2017

July 2017
Guideline on ANDAs, cannabis studies and your last chance to view our webinar on the effects of drugs on driving.
June 2017
Guideline on Equivalence Studies, Metabolic Disorders and your chance to ask our experts questions directly about hot topics like Biotherapeutics and Therapeutic Equivalence.
April 2017
EMA Guideline on Trial Master File, Reliable Data, Rescue Studies and your chance to ask our experts your questions on Pain Models and CNS Studies.
March 2017
Multisite Studies, Driving Simulation, CRO Leadership Awards and Much More!
February 2017
Learn about our cannabis study, biosimilars, our diabetes case studies, and so much more!
January 2017
Learn about our experience with pain models, our latest FDA audit, our new vaping room and so much more!

2016

December 2016
On December 2nd, the FDA published a guidance intended to assist applicants in preparing the clinical pharmacology section of prescription drug labeling.
November 2016
On November 10th, the European Medicines Agency followed through on plans to update its guidance on first-in-human clinical trials.
October 2016
For everything you need to know about our alternative solution to assess transdermal patch adhesion, our interactive timeline planning tool, and so much more!
September
Download our guide to NDA Filing Studies and learn more about our secret to on-time participant recruitment and retention.

eBulletins

2017

May 2017
We can help evaluate the effects of drugs on the ability to operate a motor vehicle, without risk of injury.
April 2017
Reliable Data. Experts you can trust.
March 2017
Are you NDA-Submission Ready?
January 2017
Thank you for making 2016 a newsworthy year!

2016

August 2016
What do you do when your trial needs a lifeline to get it back on target?
July 2016
Did you know that Altasciences has a presence on social media? Connect with us on LinkedIn, Twitter, Youtube, and our blog!
June 2016
Our clinical research campus is uniquely equipped for the evaluation of smoking cessation, smoking, vaping, tobacco risk assessment and nicotine delivery clinical trials.
May 2016
The FDA guidance states that all submissions for studies started after December 17, 2016 will require CDISC compliance.
April 2016
Think all clinical research facilities have the knowledge and expertise to conduct a trial in healthy volunteers? Think again!